IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v503y2013i7477d10.1038_nature12656.html
   My bibliography  Save this article

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Author

Listed:
  • Miki Okada-Iwabu

    (Graduate School of Medicine, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo)

  • Toshimasa Yamauchi

    (Graduate School of Medicine, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo)

  • Masato Iwabu

    (Graduate School of Medicine, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo)

  • Teruki Honma

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan)

  • Ken-ichi Hamagami

    (Graduate School of Medicine, The University of Tokyo)

  • Koichi Matsuda

    (Graduate School of Medicine, The University of Tokyo)

  • Mamiko Yamaguchi

    (Graduate School of Medicine, The University of Tokyo)

  • Hiroaki Tanabe

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan)

  • Tomomi Kimura-Someya

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan)

  • Mikako Shirouzu

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan)

  • Hitomi Ogata

    (Graduate School of Comprehensive Human Sciences, University of Tsukuba)

  • Kumpei Tokuyama

    (Graduate School of Comprehensive Human Sciences, University of Tsukuba)

  • Kohjiro Ueki

    (Graduate School of Medicine, The University of Tokyo)

  • Tetsuo Nagano

    (Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan)

  • Akiko Tanaka

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan
    Open Innovation Center for Drug Discovery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan)

  • Shigeyuki Yokoyama

    (RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan
    Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan)

  • Takashi Kadowaki

    (Graduate School of Medicine, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo
    22nd Century Medical and Research Center, The University of Tokyo)

Abstract

Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-α pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists. One of these compounds, AdipoR agonist (AdipoRon), bound to both AdipoR1 and AdipoR2 in vitro. AdipoRon showed very similar effects to adiponectin in muscle and liver, such as activation of AMPK and PPAR-α pathways, and ameliorated insulin resistance and glucose intolerance in mice fed a high-fat diet, which was completely obliterated in AdipoR1 and AdipoR2 double-knockout mice. Moreover, AdipoRon ameliorated diabetes of genetically obese rodent model db/db mice, and prolonged the shortened lifespan of db/db mice on a high-fat diet. Thus, orally active AdipoR agonists such as AdipoRon are a promising therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes.

Suggested Citation

  • Miki Okada-Iwabu & Toshimasa Yamauchi & Masato Iwabu & Teruki Honma & Ken-ichi Hamagami & Koichi Matsuda & Mamiko Yamaguchi & Hiroaki Tanabe & Tomomi Kimura-Someya & Mikako Shirouzu & Hitomi Ogata & K, 2013. "A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity," Nature, Nature, vol. 503(7477), pages 493-499, November.
    • Handle: RePEc:nat:nature:v:503:y:2013:i:7477:d:10.1038_nature12656
    DOI: 10.1038/nature12656
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature12656
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature12656?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yuya Nishida & Sachiko Yanagisawa & Rikuri Morita & Hideki Shigematsu & Kyoko Shinzawa-Itoh & Hitomi Yuki & Satoshi Ogasawara & Ken Shimuta & Takashi Iwamoto & Chisa Nakabayashi & Waka Matsumura & His, 2022. "Identifying antibiotics based on structural differences in the conserved allostery from mitochondrial heme-copper oxidases," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    2. Wenxia Wang & Swarna Bale & Jun Wei & Bharath Yalavarthi & Dibyendu Bhattacharyya & Jing Jing Yan & Hiam Abdala-Valencia & Dan Xu & Hanshi Sun & Roberta G. Marangoni & Erica Herzog & Sergejs Berdnikov, 2022. "Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:503:y:2013:i:7477:d:10.1038_nature12656. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.